Overexpression of C16orf74 is involved in aggressive pancreatic cancers

Clinical outcome of pancreatic ductal adenocarcinoma (PDAC) has not been improved in the last three decades due to the lack of effective molecular-targeted drugs. To identify a novel therapeutic target for PDAC, we have performed genome-wide anamysis and found that Homo sapiens chromosome 16 open re...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncotarget
Hlavní autoři: Nakamura, Toru, Katagiri, Toyomasa, Sato, Shoki, Kushibiki, Toshihiro, Hontani, Koji, Tsuchikawa, Takahiro, Hirano, Satoshi, Nakamura, Yusuke
Médium: Artigo
Jazyk:Inglês
Vydáno: Impact Journals LLC 2016
Témata:
Research Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5584151/
https://ncbi.nlm.nih.gov/pubmed/28881575
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.10912
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky